Jan 08, 2024 / 03:30PM GMT
Rajiv Gunasekar JPMorgan-Analyst
Hi, good morning. Welcome to the JPMorgan Healthcare Conference. My name is [Rajiv Gunasekar]. I'm with the Healthcare Investment Banking Team at JPM. This morning, I'm pleased to introduce the team from Immunome. We have their CEO, Clay Siegall, and the CSO, Jack Higgins. Thank you.
Clay Siegall - Immunome Inc - Chairman, President, Chief Executive Officer, Executive Director
Thanks, Raj. I am delighted to be here and present to you on Immunome. Before I get started, I'd like to mention that I'll be making forward-looking statements. Please refer to our SEC filings for more information.
Now, I'd like to tell you a little bit about Immunome. And it's a company that was put together in a merger in October, so only a little more than three months ago. But before I begin to tell you about Immunome, I just wanted to make one word about Seagen. I founded Seagen and built it for 25 years. I am very proud of Seagen and its impact on patients, cancer patients, and was excited to build the company over time.
And
Immunome Inc at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers